163 related articles for article (PubMed ID: 8044389)
21. Effects of a thromboxane synthetase inhibitor (OKY-046) on vascular reactivity to angiotensin II after stricture of the abdominal aorta in pregnant rabbits.
Ushijima H; Ito M; Yoshimura T; Mabe K; Okamura H
Artery; 1992; 19(2):63-75. PubMed ID: 1580798
[TBL] [Abstract][Full Text] [Related]
22. BW755C modifies endotoxin-induced respiratory failure in pigs.
Olson NC
Am J Vet Res; 1987 Mar; 48(3):444-50. PubMed ID: 3105370
[TBL] [Abstract][Full Text] [Related]
23. [Right heart function and endotoxemia in animals].
Redl G
Wien Klin Wochenschr Suppl; 1991; 188():1-20. PubMed ID: 1833887
[TBL] [Abstract][Full Text] [Related]
24. Effects of the thromboxane synthetase inhibitor, dazmegrel (UK 38,485), on pulmonary gas exchange and hemodynamics in neonatal sepsis.
Truog WE; Sorensen GK; Standaert TA; Redding GJ
Pediatr Res; 1986 May; 20(5):481-6. PubMed ID: 3520468
[TBL] [Abstract][Full Text] [Related]
25. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
Westphal M; Stubbe H; Sielenkämper AW; Ball C; Van Aken H; Borgulya R; Bone HG
Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625
[TBL] [Abstract][Full Text] [Related]
26. Systemic and regional hemodynamic effects of cyclo-oxygenase and thromboxane synthetase inhibition in normal and hyperdynamic endotoxemic rabbits.
Fink MP; Morrissey PE; Stein KL; Clement RE; Fiallo V; Gardiner WM
Circ Shock; 1988 Sep; 26(1):41-57. PubMed ID: 3142697
[TBL] [Abstract][Full Text] [Related]
27. The effect of thromboxane synthetase inhibition on cardiopulmonary function during endotoxemia in sheep.
Fujioka K; Sugi K; Traber LD; Herndon DN; Traber DL
J Burn Care Rehabil; 1990; 11(6):531-7. PubMed ID: 2286607
[TBL] [Abstract][Full Text] [Related]
28. Platelet activating factor antagonism improves cardiovascular function in non-hypotensive sepsis in pigs.
Abu-Zidan FM; Walther S
Eur J Surg; 1996 Jun; 162(6):499-504. PubMed ID: 8817228
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
30. [Thromboxane A2 synthase inhibitor and receptor antagonist].
Minoguchi K; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1986-91. PubMed ID: 11676143
[TBL] [Abstract][Full Text] [Related]
31. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
32. Effects of BM-573, a novel thromboxane A2 inhibitor, on pulmonary hemodynamics in endotoxic shock.
Lambermont B; Ghuysen A; Dogné JM; Kolh P; Tchana-Sato V; Morimont P; Benoit P; Gérard P; Masereel B; D'Orio V
Arch Physiol Biochem; 2003 Jul; 111(3):224-31. PubMed ID: 14972744
[TBL] [Abstract][Full Text] [Related]
33. Thromboxane receptor blockade (SQ 29,548) in group B streptococcal toxin challenge in young lambs.
Sandberg K; Edberg KE; Fish W; Parker RA; Hellerqvist C; Sundell H
Pediatr Res; 1994 May; 35(5):571-9. PubMed ID: 8065840
[TBL] [Abstract][Full Text] [Related]
34. Thromboxane receptor blockade in an animal model of ARDS.
Wisner D; Sturm J; Sutter G; Ellendorf B; Nerlich M
Surgery; 1988 Jul; 104(1):91-7. PubMed ID: 2968672
[TBL] [Abstract][Full Text] [Related]
35. Amrinone during porcine intraperitoneal sepsis.
Hermiller JB; Mehegan JP; Nadkarni VM; Paschall JA; Nevola JJ; Fletcher MA; Williams TJ
Circ Shock; 1991 Jun; 34(2):247-51. PubMed ID: 1934325
[TBL] [Abstract][Full Text] [Related]
36. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma.
Obase Y; Shimoda T; Matsuo N; Matsuse H; Asai S; Kohno S
Chest; 1998 Oct; 114(4):1028-32. PubMed ID: 9792572
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
38. Thromboxane synthase inhibition and cardiopulmonary function during endotoxemia in sheep.
Fujioka K; Sugi K; Isago T; Flynn JT; Traber LD; Herndon DN; Traber DL
J Appl Physiol (1985); 1991 Oct; 71(4):1376-81. PubMed ID: 1757360
[TBL] [Abstract][Full Text] [Related]
39. Cardiopulmonary changes with intermittent endotoxin administration in sheep.
Godsoe A; Kimura R; Herndon D; Flynn JT; Schlag G; Traber L; Traber D
Circ Shock; 1988 Jun; 25(2):61-74. PubMed ID: 3292076
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of thromboxane synthetase accentuates hemodynamic instability and burn edema in the anesthetized sheep model.
LaLonde C; Demling RH
Surgery; 1989 May; 105(5):638-44. PubMed ID: 2705099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
